Vistagen Therapeutics (VTGN) Non-Current Deffered Revenue (2020 - 2025)
Vistagen Therapeutics' Non-Current Deffered Revenue came in at $176,000 for fiscal Q3 2026 (quarter ended Dec 31, 2025), down 61.2% from $454,000 a year earlier and down 47.6% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Non-Current Deffered Revenue (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Vistagen Therapeutics' Non-Current Deffered Revenue was $391,000, down 85.4% from FY2024.
- Non-Current Deffered Revenue carries a four-year compound annual growth rate of -37.1% (FY2021 to FY2025).
- Going back by fiscal year, Non-Current Deffered Revenue was $2.67 million in FY2024 (+15.5%), $2.32 million in FY2023 (+48.6%), $1.56 million in FY2022 (-37.5%) and $2.49 million in FY2021.
- The fiscal Q3 2026 figure represents the lowest quarterly Non-Current Deffered Revenue in data going back to fiscal Q2 2021.
- Year-over-year, Non-Current Deffered Revenue has declined for seven consecutive quarters, with an average decline of 56.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deffered Revenue over five years came in fiscal Q3 2023 (growth of 75.5%), and the weakest in fiscal Q4 2025 (a decline of 85.4%).
- Business Quant data shows VTGN's Non-Current Deffered Revenue at $336,000 (Q2 2026), $221,000 (Q1 2026) and $391,000 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 221,000.00 |
| Mar 31, 2025 | 391,000.00 |
| Dec 31, 2024 | 454,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 2.14 Mn |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | 2.49 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.78 Mn |
| Jun 30, 2021 | 2.14 Mn |
| Mar 31, 2021 | 2.49 Mn |
API Access
Vistagen Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();